Caplight Directory>Investors>AllerFund>Allerfund


AllerFund

AllerFund

Scarsdale, New Yorkallerfund.com

Overview

AllerFund is a venture capital firm focused on creating social impact for the food allergy community. It invests in early-stage companies across various sectors, including biopharma, medical devices, diagnostics, and consumer products, with the goal of facilitating breakthroughs that can lead to cures and significantly enhance the quality of life for affected individuals. AllerFund's goal is to develop new therapies and products that will improve the lives of those living with food allergies.

Year Founded

2020

Portfolio Companies

6

Investments

CompanyDateStageLead
ANJO.AI INC.Sep 2025SeedCo-investor
AmuletAug 2024Series ACo-investor
Allergy AmuletAug 2024Series ACo-investor
IgGenixFeb 2023Series BCo-investor
AlladaptJun 2022Early FundingCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersScarsdale, New York
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.